Ildong Pharmaceutical Co., Ltd. (KRX:249420)
South Korea · Delayed Price · Currency is KRW 27,400
+800 (3.01%)
Apr 8, 2026, 3:30 PM KST
Ildong Pharmaceutical Revenue
In the year 2025, Ildong Pharmaceutical had annual revenue of 566.93B KRW, down -7.81%. Ildong Pharmaceutical had revenue of 147.02B in the quarter ending December 31, 2025, a decrease of -5.60%.
Revenue
566.93B
Revenue Growth
-7.81%
P/S Ratio
1.48
Revenue / Employee
534.34M
Employees
1,061
Market Cap
838.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 566.93B | -48.01B | -7.81% |
| Dec 31, 2024 | 614.94B | 14.18B | 2.36% |
| Dec 31, 2023 | 600.76B | -36.96B | -5.80% |
| Dec 31, 2022 | 637.71B | 77.58B | 13.85% |
| Dec 31, 2021 | 560.13B | -1.71B | -0.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daewoong | 2.07T |
| GC Biopharma | 1.99T |
| Chong Kun Dang Pharmaceutical | 1.69T |
| Dong-A Socio Holdings | 1.43T |
| Boryung | 1.02T |
| DongKook Pharmaceutical | 926.88B |
| Huons Global | 847.45B |
| JW Pharmaceutical | 775.30B |